Principal Financial Group Inc Xeris Biopharma Holdings, Inc. Transaction History
Principal Financial Group Inc
- $176 Billion
- Q2 2025
A detailed history of Principal Financial Group Inc transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 153,937 shares of XERS stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
153,937
Previous 113,746
35.33%
Holding current value
$1.5 Million
Previous $624,000
15.06%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding XERS
# of Institutions
215Shares Held
89.8MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$101 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$95.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$37.4 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$36.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$35.6 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.33B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...